Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No Couch it's going to be .2175 then I'm going to cancel as soon as it hits .2155 because the PPS is going to hit .40 by November! When the stock only hits .3999 I'm going to tell everyone how bad ELTP is as an investment. I'm so confused can you help me decide?
Taking investment advice from message board posters instead of doing your own DD?
I know I'm making the right choice by only researching the companies I want to buy stock in. ELTP is one of those!!!
This stock isn't about hype. I suggest you listen to the CC's and read the PR's that are put out once a month or so. That will give you a better understanding of the kind of company that you're "invested" in.
True! I have buddies at work that saw the stock at .068 and "thought" about buying and when it spiked to .168 they wish they had. Now the same buddies still haven't bought in and I'm wondering why? Cold feet is what separates those that make money and those that don't. Now my boss finally bought over 100k shares during the run up and after his own DD he finally believes.
As others have pointed out, this is a healthy consolidation to establish a new base and then move higher. With so much good news that could hit any day, one has to wonder why people wait on the sidelines to jump in.
The idea that Novel could sell any day in the amount of $15M-$45M could send the PPS to new levels. With roughly $4-$5M in total debt that sale would bring ELTP debt free as a company, which is rare for an OTCBB stock. Not to mention fund all of ART products if they choose to and eliminate the remaining preferred shares. A stock buy back is also a possibility.
And yet, as lasers has pointed out, a 48% gain in 10 days. I will take that any day. Who in their right mind would complain about that kind of return?
And that's why ELTP is so unique in this OTCBB. No "pumping" out PR's just to keep the PPS up or to continue the rally. They will release news when it's relevant.
Don't be surprised if there are more share purchases at the high only to complain when it drops. It's like a zippo lighter... flip the top open and close.
"Buy on the dips because ART Oxycodone is coming!"
Nice rebound! ELTP usually puts out news on Tuesdays/Thursdays so those that sold today will have to chase tomorrow if a PR is released. Still holding my shares and will continue to buy on the dips.
Lol you are assuming that elite won't have a partner. Last i checked PTIE and Acura Pharm seem to be doing well with their PPS with less than 100m market cap and zero products/revenues.
Far cry from the 90% failure rate.
Where are you getting that percentage from? All drugs entering P3 trials has a 78% approval rate. I will take that any day. I suggest doing a little better research than throwing up numbers hoping it's correct.
Agreed...eom.
ELTP doesn't need a RS to hit the big board. One ART drug will take it to AMEX/NASDAQ/ect. If PFE can have 6.61 Billion shares, yes BILLIONS, 480M is nothing with a whole line of ART drugs.
Wish I had some powder to paint it green. If people want to sit on the sideline and take a risk of losing out on possible news Monday then I feel for them.
In two years that rule isn't going to apply to ELTP. IMO, the first ART drug launch is going to send the PPS to new highs. As the new CEO stated, just 1 ART drug will bring ELTP to $4-$5 and his goal is to see a whole line if ART drugs on the market.
Oxycodone ART
Morphine Sulfate ART
Hydrocodone ART
Fentanyl ART
Methadone ART
Any current narcotic on the market will have ELTP's ART if the CEO has anything to do with it.
Slight pullback is healthy but imo we will close above .16. Possible news Monday will have people buying up during power hour.
ELTP hiring another Lab Analyst...always a good thing for a company to be hiring.
http://www.elitepharma.com/employment_opportunities.asp
Still have tomorrow! At this rate we could see .20 tomorrow and if news hits watch out!
Never to late to buy in now. So many positives that are happening with the company that you'll be saying the same thing by the end of December. I'm still buying at these levels.
Great post Jimmy. Also keep in mind that I also believe that Medicare/Medicaid can mandate that any prescription opiates are only covered if it has ELTP's two bead ART. Also insurance companies like HUMANA, Blue Cross, United Healthcare, Aetna, ect... can mandate that as well.
That would deter new investors and the old one's to immediately sell their shares. R/S don't work in the OTCBB!
Those are good points but keep in mind our OS was nowhere near what we have now. Until ELTP announces a partner for ELI-216 we will be stuck in this range. Even CFP or the sale of Novel won't push us that much higher. One drug that is FDA approved with ELTP's ART will also push the PPS significantly higher. So bottom line is until a partner is announced or an FDA approved opiate with ELTP's ART is approved and launched, we will continue to stay stagnant. I hate to say it but our OS is hurting the PPS but I fully understand and approved the increase. Without it we wouldn't have our shares. Continue to buy more at these levels because in a couple of years those that didn't will be wishing and kicking themselves.
Nice post. Like to add PTIE a company that doesn't have any products, zero revenues, and their only claim to fame is milestone payments for Remoxy from PFE which hasn't received FDA approval and won't at least for this year and possibly next. Imagine if ELTP partnered with a major pharma company? What would our shares be worth?
PTIE- zero products but with only 95M OS trading at $4.50+
ELTP- 7 products launched, 1 about to be launched, their own ART for all forms of opiates, Novel investment of 10M-50M, 350M+ OS trading at .07+
I'll keep buying ELTP. I'll trade 250M shares with actual products in the market gaining market share over a company that has zero. That doesn't even include whats in the pipeline!
What would be funny is an announcement by the FDA to award ELTP a fast track on just one of their ART drugs. The PPS would move considerably and with these patents, FDA generic ADT/ART drug mandate, it could happen.
Name me one company that has never diluted their stock in order to execute their business plan? I'll name you a few that has... PFE, C, BAC, the list goes on and on. Once ELTP has one product out in the market pimpin' their ART the OS isn't going to matter just like it doesn't matter for PFE which has over 7.3 BILLION shares!
I personally can't wait for ELTP to hit .125 shares in the very near term.
That's not gonna happen. The media doesn't cover penny stocks. Only way to actually get coverage is if ELTP partners with a large pharma company to fund all P3 and beyond for Eli-216 and then actually launches just one product with their ART. OR if a large pharma decides to buyout ELTP for their ART. Both are very realistic especially since the pain management side of healthcare continues to increase in demand each and every year.
I would normally agree with that statement but as of right now the lack of being CFP is what's keeping the PPS low. Once ELTP announces being CFP AND follows up with a forecast of being CFP from that point on the PPS will skyrocket. Keep in mind that is not including news on either a partner for P3 testing, Novel sale, additional products being approved/launched.
With the sale of Novel at $10-30M ELTP will have so many more options including buying additional ANDA's to increase revenue streams. What I'd prefer to see is the retirement of the preferred shares so they save on dividend payments each quarter, full funding of all their ART drugs, buy more ANDA's, and possibly buy back some shares. The latter isn't so important as long as they continue to increase revenues. Plus it will only take one product of their ART launched to take ELTP to a big board or possible buyout. Either way us longs are set as long as JT and his executives continue to execute their business plan.
And you know this how? Do you sit on the BOD or are you in the meetings that are conducted between the executives to make such a claim?
They need to do something. The PPS isn't going anywhere but down until the company releases a PR about the status of anything. Until that happens we'll be stuck in the .06-.07 range which is a good buying opportunity but at this point I'd rather see the company release a PR.
Agreed Couch. What will be more significant is if TJ announces that these two launches will make ELTP CFP. Common sense dictates the more products ELTP has to sell the higher the revenues which means a higher PPS. I here for the patents and for the long haul so any other news is just icing on the cake. Now a Novel sale of $20M+ would just about triple the PPS if not take us past .26 cents.
I know so many fat people on Phentermine right now. I saw their bottles and was stoaked because it had ELTP on the outside label.
Seems like PTIE isn't that hot of a stock. With only 45M shares in the OS, $56M cash, and "not perceived as a generic company", like that has any bearing in the PPS, why isn't the stock worth more than $3.40? Maybe because they don't have much to offer the market other than Remoxy and that isn't approved yet. So they have no other drugs in their pipeline and their saving grace is being in bed with Pfizer for a drug that is still in trials. I'll take ELTP over PTIE even with a 357 million OS. Let me remind you about ELTP:
5 drugs launched
3 drugs pending launch by the end of March and mid April
10% Novel stake monetized which will eliminate their debt of ONLY 3.5 million, eliminate the preferred shares which will stop quarterly dividends which basically improves their balance sheet. Also can fund ALL of their P3 ART drugs.
A new patent approval that will be announced mid April for eli-216.
PTIE doesn't sell a thing. They have no revenues other than milestone payments from PFE and that's if they are successful with Remoxy.
Is the risk on losing out on a "run" worth the very small incremental gain on getting the stock lower than its current levels? Come on dude I thought you were smarter than that. .07 is a screaming buy and no chart is going to disprove that. With news right around the corner don't take the risk of losing out on bigger gains my friend. I'm going to continue to buy at these levels knowing what's on the horizon.
3 drug launches by EOM March and April.
ELI-216 patent award due mid April--Mail Notice of Allowance given.
Cash Flow Positive by next quarter
ELI-216 Partner for P3 testing. BE Studies/Human trials underway.
Sale of Novel stake worth to be around $10-40M
This is just to name a few. Keep in mind the ANDA/NDA's applied for that haven't been discussed in detail by management.
Who said March 21st? The company, whom you should be listening too, stated the launch will occur by the end of March, not March 21st. You need to listen to the CC again.
And us longs aren't willing to sell either unless the price is right!
Nice post Tommy. The first patent was on the polymer/coating of the drugs and this new patent allows the creation of the two bead system. Ya I'd say ELI-216 is on it's way to being fully commercialized! At this point I'd rather leave it up to management about either finding a partner or going on their own. In Management I Trust...they continue to execute their business plan and have made good on everything they stated in their CC's.
They are two separate drugs but with the same one bead tech. My point being that when providers, doctors, and health insurance companies are given an option they will choose the two bead method over the one.
Last I checked two is better than one and when physicians have a choice between a one bead ART vs. a two bead ART they are going to prescribe the two bead. The pharmacist and two doctors that I work with have already seen ELTP's ART and stated to me that it is a superior method of curbing abuse vs. anything they have seen in the market. All three are aware of Embeda's issues and have very little faith in that one bead tech. Go ahead and pump PFE's tech. The only thing PFE has on ELTP is the funds to start and finish all phases to get FDA apprvoal but if you can't solve the issues it's pointless anyways. Do you seriously believe the FDA is going approve AL-02 when AL-01 has been discontinued? You say they aren't the same...where's your links proving that?